(Q33851162)

29 July 2017

1 reference

title

Biological markers in superficial bladder tumors and their prognostic significance (English)

1 reference

29 July 2017

1 reference

Zlotta AR

1

1 reference

PubMed ID

10696257

29 July 2017

Schulman CC

series ordinal

2

1 reference

PubMed ID

10696257

29 July 2017

language of work or name

1 reference

1 February 2000

1 reference

Urologic Clinics of North America

29 July 2017

1 reference

29 July 2017

27

1 reference

29 July 2017

179-89, xi-xii

1 reference

29 July 2017

1

1 reference

Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Prognostic value of Ki-67 for recurrence and progression of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Nuclear accumulation of mutant p53 protein: a possible predictor of failure of intravesical therapy in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Cancer progression and p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Frequent and heterogeneous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

p53 mutations in human bladder cancer: genotypic versus phenotypic patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Assessing p53 status in breast cancer prognosis: where should you put the thermometer if you think your p53 is sick?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Intravesical bacillus calmette-guerin (BCG) as inducer of tumor-suppressing proteins p53 and p21 Waf1-Cip1 during treatment of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Immunohistological expression of p53 in primary pT1 transitional cell bladder cancer in relation to tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Significance of p53 overexpression in urinary bladder transitional cell carcinoma in situ before and after bacillus Calmette-Guérin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

p53 and p53-regulated genes in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Correlation between p53 over expression and response to bacillus Calmette-Guerin therapy in a high risk select population of patients with T1G3 bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Prognostic markers of intravesical bacillus Calmette-Guérin therapy for multiple, high-grade, stage T1 bladder cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Long-term efficacy of intravesical bacillus Calmette-Guerin for carcinoma in situ: relationship of progression to histological response and p53 nuclear accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

p53 status does not predict initial clinical response to bacillus Calmette-Guerin intravesical therapy in T1 bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Comparative analysis of MiB1 and p53 expression in human bladder tumors and their correlation with cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

p53 mutations in bladder tumors inactivate the transactivation of the p21 and Bax genes, and have a predictive value for the clinical outcome after bacillus Calmette-Guerin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

P53 accumulation, deoxyribonucleic acid ploidy and progression of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Growth fractions in bladder cancer defined by Ki67: association with cancer grade, category and recurrence rate of superficial lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Overexpression of p53 protein and its significance for recurrent progressive bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: correlation with Ki67 index

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970246-9

7 January 2021

10.1016/S0094-0143(05)70246-9

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10696257